{
  "trial_id": "NCT02104804",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), duration of diabetes, baseline HbA1c, fasting plasma glucose (FPG), type of insulin regimen, use of metformin, renal function (creatinine clearance), liver function tests, cardiovascular history, history of psychiatric disorders, history of alcohol or drug abuse, anemia status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Baseline HbA1C",
          "baseline HbA1c"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "fasting plasma glucose (FPG)"
        ],
        [
          "Metformin use at enrolment",
          "use of metformin"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "0-180 min Post Prandial Glucose AUC",
        "120-min Post Prandial Glucose",
        "Fasting Glucagon",
        "Fasting C-peptide",
        "Mean Tolerated Daily Dose of Insulin"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "type of insulin regimen",
        "renal function (creatinine clearance)",
        "liver function tests",
        "cardiovascular history",
        "history of psychiatric disorders",
        "history of alcohol or drug abuse",
        "anemia status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Fasting Plasma Glucose, Duration of Diabetes, Insulin Dose, Use of Metformin, Creatinine Clearance,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline HbA1C",
          "Baseline HbA1c"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Metformin use at enrolment",
          "Use of Metformin"
        ]
      ],
      "remaining_reference_features": [
        "0-180 min Post Prandial Glucose AUC",
        "120-min Post Prandial Glucose",
        "Fasting Glucagon",
        "Fasting C-peptide",
        "Mean Tolerated Daily Dose of Insulin"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Insulin Dose",
        "Creatinine Clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Insulin Dose, Body Mass Index, HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Triglycerides, HDL Cholesterol, LDL Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline HbA1C",
          "HbA1c"
        ],
        [
          "Duration of diabetes",
          "Diabetes Duration"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Metformin use at enrolment",
          "Region of Enrollment"
        ],
        [
          "Mean Tolerated Daily Dose of Insulin",
          "Insulin Dose"
        ]
      ],
      "remaining_reference_features": [
        "0-180 min Post Prandial Glucose AUC",
        "120-min Post Prandial Glucose",
        "Fasting Glucagon",
        "Fasting C-peptide"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, body mass index, duration of diabetes, HbA1c, FPG, insulin dose, metformin dose, systolic blood pressure, diastolic blood pressure, heart rate, creatinine clearance, serum creatinine, liver function tests, history of cardiovascular disease, history of hypertension, history of dyslipidemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline HbA1C",
          "HbA1c"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "FPG"
        ],
        [
          "Metformin use at enrolment",
          "metformin dose"
        ],
        [
          "Mean Tolerated Daily Dose of Insulin",
          "insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "0-180 min Post Prandial Glucose AUC",
        "120-min Post Prandial Glucose",
        "Fasting Glucagon",
        "Fasting C-peptide"
      ],
      "remaining_candidate_features": [
        "race",
        "body mass index",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "creatinine clearance",
        "serum creatinine",
        "liver function tests",
        "history of cardiovascular disease",
        "history of hypertension",
        "history of dyslipidemia."
      ]
    }
  }
}